Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

The Children's Hospital at Westmead, Westmead

The Royal Children's Hospital, Parkville

Columbia University, New York

Hopital d'Enfants CHU Timone, Marseille

Children's Hospital of Philadelphia, Philadelphia

Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan

Duke University Medical Center, Durham

Child Neurology Center of NW Florida, Gulf Breeze

Cincinnati Children's Hospital Medical Center, Cincinnati

University of Iowa Children's Hospital, Division of Child Neurology, Iowa City

University of Minnesota, Minneapolis

Washington University Medical School, St Louis

University of Kansas Medical Center, Kansas City

Southwestern University, Dallas

Department of Rehabilitation, The Children's Hospital, Aurora

University of Utah, Salt Lake City

University of California - Davis, Sacramento

Shriners Hospital for Children-Portland, Portland

Children's Hospital of Boston, Boston

UZ Leuven, Leuven

Alberta Children's Hospital, London

Children's Hospital of Western Ontario, London

British Colombia Children's Hopsital, Vancouver

Laboratoire d'Exploration Fonctionnelles, Nantes

Groupe Hospitalier Pitie-Salpetriere, Institut de Myologie, Paris

University of Essen - Clinic for Children, Essen

University Hospital, Freiburg im Breisgau

Hadassah University Hopspital, Jerusalem

Hospital Sant Joan de Deu, Barcelona

Hospital Universitario La Fe, Valencia

Astrid Lindgren Pediatric Hospital, Stockholm

UCL Instititute of Child Health, Dubowitz, London

University of Newcastle, Newcastle upon Tyne

Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry

Ospedale Pediatrico Bambino Gesu, Roma

U.O. Complessa di Neuropsichiatria Infantile-Policlinico A. Gemelli-Universita Cattolica, Roma

Queen Silvia Children's Hospital, Gothenburg